Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Claus Lamm
Do We Care About the Powerless Third? An ERP Study of the Three-Person Ultimatum Game
Frontiers in Human Neuroscience
Mental Health
Neuropsychology
Physiological Psychology
Neurology
Behavioral Neuroscience
Psychiatry
Biological Psychiatry
“Feeling” the Pain of Those Who Are Different From Us: Modulation of EEG in the Mu/Alpha Range
Cognitive, Affective and Behavioral Neuroscience
Behavioral Neuroscience
Cognitive Neuroscience
Social Dimension and Complexity Differentially Influence Brain Responses During Feedback Processing
Social Neuroscience
Development
Social Psychology
Behavioral Neuroscience
A Functional Polymorphism in the Prodynorphin Gene Affects Cognitive Flexibility and Brain Activation During Reversal Learning
Frontiers in Behavioral Neuroscience
Cognitive Neuroscience
Physiological Psychology
Behavioral Neuroscience
Neuropsychology
Restriction of Task Processing Time Affects Cortical Activity During Processing of a Cognitive Task: An Event-Related Slow Cortical Potential Study
Cognitive Brain Research
Related publications
Neuropsychiatric Outcomes After Stroke – Authors' Reply
The Lancet Neurology
Neurology
Maximising the Value of Research for Brain Health
The Lancet Neurology
Neurology
Cannabidiol in Patients With Treatment-Resistant Epilepsy
The Lancet Neurology
Neurology
WHO Takes Up the Baton on Dementia
The Lancet Neurology
Neurology
Learning About the Brain With Comics
The Lancet Neurology
Neurology
Functional (Psychogenic) Saccadic Oscillations and Oculogyric Crises – Authors' Reply
The Lancet Neurology
Neurology
Dream Weaver
The Lancet Neurology
Neurology
The Evolution of Universally Accessible Building Design
The Lancet Neurology
Neurology
Global, Regional, and National Burden of Meningitis, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016
The Lancet Neurology
Neurology
Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial
The Lancet Neurology
Neurology
